Korean J Psychopharmacol.
2008 Dec;19(6):341-347.
Aberrant Response of Selective Serotonin Reuptake Inhibitor in Two Patients with High N100 Amplitude Slope
- Affiliations
-
- 1Department of Psychiatry, Ilsanpaik Hospital, College of Medicine, Inje University, Goyang, Korea.
- 2Department of Clinical Emotion and Cognition Research Laboratory, Ilsanpaik Hospital, College of Medicine, Inje University, Goyang, Korea.
- 3Department of Psychiatry, Cheonan-JoongAng Hospital, Cheonan, Korea.
- 4Graduate Program in Cognitive Science, Yonsei University, Seoul, Korea.
Abstract
- Serotonin is one of the most important neurotransmitters involved in the pathophysiology of depressive illness. The assessment of alteration of cerebral serotonin has been still controversial but interesting topic to study. Recently, increasing evidence has accumulated that the N100 amplitude slope reflects cerebral serotonin activity and treatment response of selective serotonin reuptake inhibitors (SSRIs). We report on two patients who showed abrupt mood changes and side effects after taking SSRI antidepressants. In both patients, aberrantly high N100 amplitude slopes were observed. Our cases suggest that the N100 amplitude slope may be a reliable indicator for predicting manic conversion and side effects in the SSRI treatment of depressive patients. Controlled studies are necessary to confirm whether a high N100 amplitude slope is a useful indicator of SSRI supersensitivity.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- N100 Amplitude Slopes in Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Normal Controls
- Probable tramadol-induced atypical serotonin syndrome in a patient receiving selective serotonin reuptake inhibitor and stopped at 10 days before surgery: A case report
- The Role of Serotonin in pathology and Treatment of the Mood Disorders
- Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression
- Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT₃ receptor currents in NCB-20 cells
